Search clinical trials for: Rabies post-exposure prophylaxis

Total 2551 results

Novartis Vaccines

Completed

Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules

Rabies

India
Novartis Vaccines

Completed

Purified Rabies Vaccine for Human Use (Chick-embryo Cell)

Rabies Post-exposure Prophylaxis

China
Kempegowda Institute of Medical Sciences, Bangalore

Recruiting

A Comparison of Safety and Immunogenicity of Rabies Pre Exposure Prophylaxis Regimen Between Gvt of India Approved and WHO Approved.

Vaccine Reaction

India
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Recruiting

Study to Evaluate GR1801's Efficacy and Safety

Rabies Post-exposure Prophylaxis

China
The Methodist Hospital Research Institute
Grifols Biologicals, LLC

Recruiting

Survey of Human Rabies Immune Globulin Safety in Children

Rabies | Rabies Human | Pediatrics | Rabies Virus Infection

United States
Johns Hopkins University
Centers for Disease Control and Prevention

Recruiting

Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC) (EHPOC)

HIV Infections | Syphilis

United States
Emergent BioSolutions
Department of Health and Human Services

Completed

Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults

Anthrax

United States
Emergent BioSolutions
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels

Anthrax

United States
Emergent BioSolutions
Department of Health and Human Services

Completed

Ciprofloxacin BioThrax Co-Administration Study

Anthrax

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland

Rabies (Healthy Volunteers)

Thailand
Sanofi Pasteur, a Sanofi Company

Completed

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland

Rabies (Healthy Volunteers)

Thailand
Synermore Biologics (Suzhou) Co., Ltd.
Simoon Record Pharma Information Consulting Co., Ltd.

Completed

A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety

RNA Virus Infections | Virus Diseases | Mononegavirales Infections | Rabies | Rhabdoviridae Infections | Communicable Disease

China
Institut Pasteur
Institut Pasteur de Madagascar; Institut Pasteur du Cambodge

Completed

Immunity Persistence After Abridged Intradermal Rabies PEP (RESIST-3)

Rabies

Cambodia, Madagascar
Institut Pasteur du Cambodge
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia

Rabies Post-exposure Prophylaxis

Cambodia
Synermore Biologics Co., Ltd.
Synermore Biologics USA Limited

Completed

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies (ARPEP)

Rabies

United States, Philippines
State University of New York - Upstate Medical...
Walter Reed Army Institute of Research (WRAIR)

Completed

Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis (RABVAX)

Rabies

United States
Washington State University

Completed

Phone Text Message Reminders on Compliance With Human Rabies Post Exposure Prophylaxis Project

Rabies

Kenya
Sanofi Pasteur, a Sanofi Company

Completed

Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year (VAJ00001)

Healthy Volunteers (Rabies Immunization)

Philippines
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen

Rabies

Philippines
GlaxoSmithKline

Active, not recruiting

A Clinical Study to Evaluate Immune Responses to Rabies Vaccine in Adults Who Received Different Primary Rabies Vaccination Regimens

Virus Diseases

Austria, Germany, Switzerland
University of Washington
Bill and Melinda Gates Foundation

Completed

Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

COVID-19 | Corona Virus Infection | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)

United States
The Methodist Hospital Research Institute
Grifols Biologicals, LLC

Completed

Improving Adherence to Rabies PEP Guideline Recommendations

Rabies | Rabies Human | Rabies Virus Infection

United States
State University of New York - Upstate Medical...
Walter Reed Army Institute of Research (WRAIR); Kansas State University

Completed

Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis. (MALRAB)

Rabies

United States
Postgraduate Institute of Medical Education and...

Completed

Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 (PEP-CQ)

CoVID-19

India
Ross University School of Veterinary Medicine
Serum Institute of India Pvt. Ltd.

Completed

Safety of Rabivax-S for Pre-exposure Prophylaxis

Rabies Vaccine Adverse Reaction

Saint Kitts and Nevis
GlaxoSmithKline

Withdrawn

A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children

Virus Diseases
Sanofi Pasteur, a Sanofi Company

Completed

Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen

Rabies

Philippines
GlaxoSmithKline

Completed

A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children

Virus Diseases

China
Mahidol University
VINS Bioproducts Ltd.; Biogentech Co.,LTD

Completed

Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients

Rabies

Thailand
Novartis Vaccines

Completed

Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects

Japanese Encephalitis | Rabies

Austria, Germany, Switzerland
Leiden University Medical Center

Unknown

One-visit Multi-site Intradermal Rabies Vaccination - Dose Finding

Rabies Pre-exposure Prophylaxis

Netherlands
Crucell Holland BV

Completed

Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy Adults

Rabies

India
Crucell Holland BV

Completed

Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

Rabies

Philippines
Crucell Holland BV

Completed

A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects

Rabies

United States
Peking University People's Hospital

Unknown

Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose

Rabies

China
Mahidol University
Chiron company: Clinical Research and Medical Affairs

Completed

Rabies Immunization Concomitant With JEV in Children

Rabies
Novartis
Novartis Vaccines

Completed

Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers

Japanese Encephalitis | Rabies | Pre-Exposure Prophylaxis

Thailand
Case Comprehensive Cancer Center
AbbVie; Genmab; Recordati Rare Diseases

Not yet recruiting

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

Non-Hodgkin Lymphoma | Cytokine Release Syndrome

United States
Universitas Diponegoro

Recruiting

Biomarkers & Infection After Prophylactic Antibiotic in Cardiac Implantable Electronic Device Implantation (BI-PACED)

Heart Block | Biomarkers | Antibiotic Prophylaxis | CIED Related Infection | CIED-related Infections
Anhui Provincial Hospital

Recruiting

Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT

Cytomegalovirus Infection Reactivation

China
Mahidol University

Not yet recruiting

Role of Ultrasound Guide Greater Occipital Nerve Block at Second Cervical Vertebra in Migraine Headache Prophylaxis

Migraine Disorders

Thailand
Tanta University

Not yet recruiting

Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity

Breast Cancer | Doxorubicin Induced Cardiomyopathy

Egypt
University of Massachusetts, Worcester
National Institute on Drug Abuse (NIDA); University of Zambia

Recruiting

Zambia Healthy Choices Project for Emerging Adults Living With HIV

Pre-Exposure Prophylaxis

Zambia
Johns Hopkins University
National Institutes of Health (NIH); Desmond Tutu HIV Foundation

Not yet recruiting

Universal Test and Connect for HIV Service Delivery in South Africa (UTC-SA)

Human Immunodeficiency Virus | Emergency Department | Pre-Exposure Prophylaxis | South Africa
University of California, San Francisco

Not yet recruiting

PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest (PROSPER)

Heart Arrest, Seizure, Status Epilepticus

United States
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Recruiting

Evaluation of VSS Antibiotic Prophylaxis in Prosthetic Surgery (MRSA) (MRSA)

Infection in Bone

Italy
Ohio State University

Not yet recruiting

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Preterm Birth | Pregnancy, High Risk | Preterm Premature Rupture of Membrane

United States
University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH)

Not yet recruiting

Supporting Oral Pre-exposure Prophylaxis Decision Making Among Pregnant Women in Lilongwe, Malawi

HIV Prevention

Malawi
Walter Reed National Military Medical Center

Recruiting

Bladder Botox UTI Antibiotic Prophylaxis

Overactive Bladder | Bladder Pain Syndrome

United States
Shanghai Escugen Biotechnology Co., Ltd

Not yet recruiting

A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer

Metastatic Breast Cancer

China

Search clinical trials for: Rabies post-exposure prophylaxis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations